SEROPREVALENCE OF ANTI-SARS-COV-2 ANTIBODIES IN FRONT-LINE MEDICAL AND NON-MEDICAL STAFF AT THE JORDAN MEDICAL SERVICES, CAMEROON: DESCRIPTIVE CROSS-SECTIONAL STUDY

Authors

  • Nadège Lylian Doumou A Mvomo Jordan Medical Services, Cameroon
  • Esther Voundi Voundi Faculty of Medicine and Biomedical Sciences of the University of Yaoundé I, Cameroon
  • Ruth Ngongang Jordan Medical Services, Cameroon
  • Yimga Sam Blessing Jordan Medical Services, Cameroon
  • Herman Tchida Tassonwa Jordan Medical Services, Cameroon Catholic University of Central Africa.
  • Eric Nseme Etouckey Faculty of Medicine and Biomedical Sciences of the University of Yaoundé I, Cameroon
  • Haamit Kabir Abba Faculty of Medicine and Biomedical Sciences of the University of Yaoundé I, Cameroon
  • Eric Tollo Chokote Jordan Medical Services, Cameroon
  • Gilles Tchouassi Simeni Jordan Medical Services, Cameroon
  • Jean Paul Assam Assam Faculty of Sciences of the University of Yaoundé I, Cameroon

DOI:

https://doi.org/10.53555/nnpbs.v8i4.1206

Keywords:

Seroprevalence, Health Care Workers, Non-Healthcare Workers, SARS-CoV 2, Cameroon

Abstract

Introduction: Health care personnel on the front line of the COVID-19 pandemic represent a source of transmission. The aim of our study was to assess the seroprevalence of anti-SRAS-Cov-2 antibodies in nursing and non-healthcare staff at the Jordan Medical Services (JMS).

Materials and method: We conducted a descriptive cross-sectional study of JMS staff during April 2021 recruited consecutively after obtaining their informed consent. Immunoglobulin G and M were detected using the Panbio TM COVID-19 IgG/IgM kit. The data collected were analysed using SPSS version 21 software. The Chi-square test was used with a statistical significance of p<0.05.

Results: Of the 170 participants, the most represented age group was [30-40[ years (86, 50.6%) with a female participation rate of 55.9% (95) and a predominance of paramedical staff (90, 52.9%). The seroprevalence of COVID-19 was 6.5% (11) for IgM and 44.7% (76) for IgG. The proportion of paramedical staff who were IgG positive for COVID-19 was statistically significantly higher than that of medical and administrative staff, at 52.2% (p = 0.037). On the other hand, the proportion of participants with a history of COVID-19 positive for IgG was statistically higher than that of the others, at 61.5% (p = 0.016).

Conclusion: Seroprevalence of COVID-19 is high among health care and non-health care personnel, with paramedical personnel and history of COVID-19 as associated factors.

References

Juma CA, Mushabaa NK, Abdu Salam F, Ahmadi A, Lucero-Prisno DE. COVID-19: The Current Situation in the Democratic Republic of Congo. Am J Trop Med Hyg. déc 2020;103(6):2168 70.

Suivez la propagation de la COVID-19 à travers le monde [Internet]. Le Devoir. [Cité 18 oct 2021]. Disponible sur : https://www.ledevoir.com/documents/special/20-03_covid19-carte-dynamique/index.html

Atténuer l’impact de la COVID-19 sur les services de santé essentiels, OMS, 05 novembre 2020.

To KK-W, Tsang OT-Y, Leung W-S, Tam AR, Wu T-C, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases. 1 mai 2020;20(5):565 74.

Elsevier. Les professionnels de santé face à la pandémie de la maladie à coronavirus (COVID-19) [Internet]. Elsevier Connect. [Cité 20 oct 2021]. Disponible sur : https://www.elsevier.com/fr-fr/connect/psy/les-professionnels-de-sante-face-a-la-pandemie-de-la-maladie-a-coronavirus-covid-19

Garcia-Basteiro AL, Moncunill G, Tortajada M, Vidal M, Guinovart C, Jiménez A, et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nature Communications [Internet]. 2020 [Cité 12 oct 2021];11. Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343863/

Venugopal U, Jilani N, Rabah S, Shariff MA, Jawed M, Mendez Batres A, et al. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis. janv 2021; 102:63 9.

Etyang AO, Lucinde R, Karanja H, Kalu C, Mugo D, Nyagwange J, et al. Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya. Clin Infect Dis. 24 avr 2021 ; ciab346.

Venugopal U, Jilani N, Rabah S, Shariff MA, Jawed M, Mendez Batres A, et al. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis. janv 2021; 102:63 9.

Olatunde Olayanju, Olabisi Bamidele, Fabian Edem, Bola Eseile, Abimbola Amoo, Jude Nwaokenye, Chioma Udeh, Gabriel Oluwole, Gabriel Odok, and Nnaemeka Awah. SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria [Internet]. [Cité 19 juill 2021]. Disponible sur : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790104/

Haoud K, Mellali S, La phytothérapie et les produits naturels au secours de la médecine conventionnelle dans le traitement et la prévention de la COVID-19, Algerian Journal of Health Sciences.vol. 03 num. 03 (2021) 79-87.

Chen H, Zhang X, Liu W, Xue M, Liao C, Huang Z, et al. The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients. Int Immunopharmacol. févr 2021; 91:107325.

Cherif K, Ernandes H, Hannachi S, Chtourou S, Abid R, Ben Moussa M, Besghaier H, Bellaaj R, Battikh R, COVID-19 chez le personnel de santé travaillant à l’Hôpital Militaire de Tunis, STPI et SPILF, 2021, P140.

Hall VJ, Foulkes S, Saei A, Andrews N, Oguti B, Charlett A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. The Lancet. 2021; 397(10286):1725–35.

OMS, Éléments à prendre en considération lors de la mise en œuvre et de l’ajustement des mesures de santé publique et des mesures sociales dans le cadre de l’épidémie de COVID-19, Orientations provisoires, 14 juin 2021.

Downloads

Published

2022-04-13

Issue

Vol. 8 No. 4 (2022): Journal of Advance Research in Pharmacy & Biological Science (ISSN: 2208-2360)

Section

Articles

License

Copyright (c) 2022 Journal of Advance Research in Pharmacy & Biological Science

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

 
 

How to Cite

Mvomo , N. L. D. A. ., Voundi , E. V. ., Ngongang, R. ., Blessing , Y. S. ., Tassonwa, H. T. . ., Etouckey , E. N. ., Abba , H. K. ., Chokote , E. T. ., Simeni , G. T. ., & Assam , J. P. A. . (2022). SEROPREVALENCE OF ANTI-SARS-COV-2 ANTIBODIES IN FRONT-LINE MEDICAL AND NON-MEDICAL STAFF AT THE JORDAN MEDICAL SERVICES, CAMEROON: DESCRIPTIVE CROSS-SECTIONAL STUDY. Journal of Advance Research in Pharmacy and Biological Science (ISSN 2208-2360) , 8(4), 1-8. https://doi.org/10.53555/nnpbs.v8i4.1206